Cochrane Abstracts
Anticoagulation therapy versus placebo for pulmonary hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anticoagulation Therapy Versus Placebo for Pulmonary Hypertension." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436365/all/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension.
Anticoagulation therapy versus placebo for pulmonary hypertension. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436365/all/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension. Accessed January 8, 2025.
Anticoagulation therapy versus placebo for pulmonary hypertension. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436365/all/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension
Anticoagulation Therapy Versus Placebo for Pulmonary Hypertension [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436365/all/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anticoagulation therapy versus placebo for pulmonary hypertension
ID - 436365
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436365/all/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
